Artículos de revistas sobre el tema "Estrogen Receptor - Cancer Therapeutics"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Estrogen Receptor - Cancer Therapeutics".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Arterburn, Jeffrey B. y Eric R. Prossnitz. "G Protein–Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications". Annual Review of Pharmacology and Toxicology 63, n.º 1 (20 de enero de 2023): 295–320. http://dx.doi.org/10.1146/annurev-pharmtox-031122-121944.
Texto completoMitra, Saikat, Mashia Subha Lami, Avoy Ghosh, Rajib Das, Trina Ekawati Tallei, Fatimawali, Fahadul Islam et al. "Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?" Cancers 14, n.º 3 (1 de febrero de 2022): 759. http://dx.doi.org/10.3390/cancers14030759.
Texto completoMonga, Jyoti, Niladry S. Ghosh, Somdutt Mujwar y Isha Rani. "IN SILICO STUDIES OF SOME NEWLY DESIGNED BENZIMIDAZOLETHIAZOLIDINONE BASED ANTAGONISTS OF HUMAN ESTROGEN RECEPTOR". INDIAN DRUGS 60, n.º 08 (28 de agosto de 2023): 15–30. http://dx.doi.org/10.53879/id.60.08.14087.
Texto completoChang, Minsun, Kuan-wei Peng, Irida Kastrati, Cassia R. Overk, Zhi-Hui Qin, Ping Yao, Judy L. Bolton y Gregory R. J. Thatcher. "Activation of Estrogen Receptor-Mediated Gene Transcription by the Equine Estrogen Metabolite, 4-Methoxyequilenin, in Human Breast Cancer Cells". Endocrinology 148, n.º 10 (1 de octubre de 2007): 4793–802. http://dx.doi.org/10.1210/en.2006-1568.
Texto completoShete, Nivida, Jordan Calabrese y Debra A. Tonetti. "Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches". Cancers 15, n.º 14 (17 de julio de 2023): 3647. http://dx.doi.org/10.3390/cancers15143647.
Texto completoPetrie, Whitney K., Megan K. Dennis, Chelin Hu, Donghai Dai, Jeffrey B. Arterburn, Harriet O. Smith, Helen J. Hathaway y Eric R. Prossnitz. "G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth". Obstetrics and Gynecology International 2013 (2013): 1–17. http://dx.doi.org/10.1155/2013/472720.
Texto completoMedina, Mauricio A., Goldie Oza, Ashutosh Sharma, L. G. Arriaga, José Manuel Hernández Hernández, Vincent M. Rotello y Jose Tapia Ramirez. "Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies". International Journal of Environmental Research and Public Health 17, n.º 6 (20 de marzo de 2020): 2078. http://dx.doi.org/10.3390/ijerph17062078.
Texto completoIde, Hiroki y Hiroshi Miyamoto. "Sex Hormone Receptor Signaling in Bladder Cancer: A Potential Target for Enhancing the Efficacy of Conventional Non-Surgical Therapy". Cells 10, n.º 5 (11 de mayo de 2021): 1169. http://dx.doi.org/10.3390/cells10051169.
Texto completoLucà, Rossella, Giorgia di Blasio, Daniela Gallo, Valentina Monteleone, Isabella Manni, Laura Fici, Marianna Buttarelli et al. "Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4". Cancers 11, n.º 9 (12 de septiembre de 2019): 1349. http://dx.doi.org/10.3390/cancers11091349.
Texto completoDi Zazzo, Galasso, Giovannelli, Di Donato, Bilancio, Perillo, Sinisi, Migliaccio y Castoria. "Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer". Cancers 11, n.º 10 (23 de septiembre de 2019): 1418. http://dx.doi.org/10.3390/cancers11101418.
Texto completoCai, Rong y Caroline Ajo-Franklin. "Towards Sensing of Breast Cancer Biomarkers: Engineering Glucose Dehydrogenase As an Estrogenic Regulated Protein". ECS Meeting Abstracts MA2022-02, n.º 61 (9 de octubre de 2022): 2227. http://dx.doi.org/10.1149/ma2022-02612227mtgabs.
Texto completoGupta, Ishita, Balsam Rizeq, Semir Vranic, Ala-Eddin Al Moustafa y Halema Al Farsi. "Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets". International Journal of Molecular Sciences 21, n.º 18 (15 de septiembre de 2020): 6750. http://dx.doi.org/10.3390/ijms21186750.
Texto completoVekaria, Mrudul Pravinbhai y Pravin Tirgar. "Salicin a promising ER, PR and HER2 binding molecule proving lethal against Hormone + and triple negative breast cancer cells". International Journal of Ayurvedic Medicine 12, n.º 1 (31 de marzo de 2021): 73–83. http://dx.doi.org/10.47552/ijam.v12i1.1755.
Texto completoShiota, Masaki, Naohiro Fujimoto, Eiji Kashiwagi y Masatoshi Eto. "The Role of Nuclear Receptors in Prostate Cancer". Cells 8, n.º 6 (17 de junio de 2019): 602. http://dx.doi.org/10.3390/cells8060602.
Texto completoERZURUMLU, Yalçın y Hatice Kübra DOĞAN. "Breast cancer and the molecular mechanism of estrogen signaling". Interdisciplinary Medical Journal 14, n.º 48 (30 de abril de 2023): 57–68. http://dx.doi.org/10.17944/interdiscip.1285662.
Texto completoQian, Hongyan, Jingxiu Xuan, Yuan Liu y Guixiu Shi. "Function of G-Protein-Coupled Estrogen Receptor-1 in Reproductive System Tumors". Journal of Immunology Research 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/7128702.
Texto completoRyu, Won-Ji y Joo Hyuk Sohn. "Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer". Pharmaceuticals 14, n.º 10 (30 de septiembre de 2021): 1008. http://dx.doi.org/10.3390/ph14101008.
Texto completoRenoir, Jack-Michel, Véronique Marsaud y Gwendal Lazennec. "Estrogen receptor signaling as a target for novel breast cancer therapeutics". Biochemical Pharmacology 85, n.º 4 (febrero de 2013): 449–65. http://dx.doi.org/10.1016/j.bcp.2012.10.018.
Texto completoPepermans, Richard A., Geetanjali Sharma y Eric R. Prossnitz. "G Protein-Coupled Estrogen Receptor in Cancer and Stromal Cells: Functions and Novel Therapeutic Perspectives". Cells 10, n.º 3 (17 de marzo de 2021): 672. http://dx.doi.org/10.3390/cells10030672.
Texto completoChi, David, Hari Singhal, Lewyn Li, Tengfei Xiao, Weihan Liu, Matthew Pun, Rinath Jeselsohn et al. "Estrogen receptor signaling is reprogrammed during breast tumorigenesis". Proceedings of the National Academy of Sciences 116, n.º 23 (20 de mayo de 2019): 11437–43. http://dx.doi.org/10.1073/pnas.1819155116.
Texto completoSchedin, Troy B., Virginia F. Borges y Elena Shagisultanova. "Overcoming Therapeutic Resistance of Triple Positive Breast Cancer with CDK4/6 Inhibition". International Journal of Breast Cancer 2018 (19 de junio de 2018): 1–11. http://dx.doi.org/10.1155/2018/7835095.
Texto completoBreier, Alan, Emily Liffick, Tom Hummer, Jennifer Vohs, Nicole Mehdiyoun, Ziyi Yang, Andrew J. Saykin, Brenna McDonald y Michael Francis. "S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA?" Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S43—S44. http://dx.doi.org/10.1093/schbul/sbaa031.098.
Texto completoSchuler, Linda A. y Fern E. Murdoch. "Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers". Cancers 13, n.º 15 (24 de julio de 2021): 3725. http://dx.doi.org/10.3390/cancers13153725.
Texto completoVoutsadakis, Ioannis A. "The TSH/Thyroid Hormones Axis and Breast Cancer". Journal of Clinical Medicine 11, n.º 3 (28 de enero de 2022): 687. http://dx.doi.org/10.3390/jcm11030687.
Texto completoSaha Roy, Sudipa y Ratna K. Vadlamudi. "Role of Estrogen Receptor Signaling in Breast Cancer Metastasis". International Journal of Breast Cancer 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/654698.
Texto completoStein, R. A. y D. P. McDonnell. "Estrogen-related receptor α as a therapeutic target in cancer". Endocrine-Related Cancer 13, Supplement_1 (diciembre de 2006): S25—S32. http://dx.doi.org/10.1677/erc.1.01292.
Texto completoSeachrist, Darcie D., Lindsey J. Anstine y Ruth A. Keri. "FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer". Cancers 13, n.º 20 (17 de octubre de 2021): 5205. http://dx.doi.org/10.3390/cancers13205205.
Texto completoZattarin, Emma, Rita Leporati, Francesca Ligorio, Riccardo Lobefaro, Andrea Vingiani, Giancarlo Pruneri y Claudio Vernieri. "Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications". Cells 9, n.º 12 (9 de diciembre de 2020): 2644. http://dx.doi.org/10.3390/cells9122644.
Texto completoXia, Song y Qiong Lin. "Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer". Technology in Cancer Research & Treatment 21 (enero de 2022): 153303382210903. http://dx.doi.org/10.1177/15330338221090351.
Texto completoShaleen Jain y Dr. Asmita Das. "Virtual screening of natural compounds as combinatorial agents from indian medicinal plants against estrogen positive breast cancer". International Journal on Integrated Education 3, n.º 10 (20 de octubre de 2020): 266–75. http://dx.doi.org/10.31149/ijie.v3i10.750.
Texto completoHsu, Li-Han, Nei-Min Chu, Yung-Feng Lin y Shu-Huei Kao. "G-Protein Coupled Estrogen Receptor in Breast Cancer". International Journal of Molecular Sciences 20, n.º 2 (14 de enero de 2019): 306. http://dx.doi.org/10.3390/ijms20020306.
Texto completoAlsous, Lina y Sanaa Bardaweel. "Selective Estrogen Receptor Modulators (SERMs) Synergize with Cisplatin, Induce Apoptosis and Suppress Cellular Migration and Colony Formation of Lung Cancer Cells". Anti-Cancer Agents in Medicinal Chemistry 22, n.º 9 (mayo de 2022): 1826–36. http://dx.doi.org/10.2174/1871520621666210908110902.
Texto completoHafezi, Shirin A. y Wael M. Abdel-Rahman. "The Endocrine Disruptor Bisphenol A (BPA) Exerts a Wide Range of Effects in Carcinogenesis and Response to Therapy". Current Molecular Pharmacology 12, n.º 3 (29 de julio de 2019): 230–38. http://dx.doi.org/10.2174/1874467212666190306164507.
Texto completoSkliris, George P., Etienne Leygue, Peter H. Watson y Leigh C. Murphy. "Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target". Journal of Steroid Biochemistry and Molecular Biology 109, n.º 1-2 (marzo de 2008): 1–10. http://dx.doi.org/10.1016/j.jsbmb.2007.12.010.
Texto completoGérard, Céline, Mélanie Mestdagt, Ekaterine Tskitishvili, Laudine Communal, Anne Gompel, Elisabete Silva, Jean-François Arnal et al. "Combined Estrogenic and Antiestrogenic Properties of Estetrol on Breast Cancer may provide a Safe Therapeutic Window for the Treatment of Menopausal Symptoms". Journal of SAFOMS 3, n.º 1 (2015): 31–33. http://dx.doi.org/10.5005/jsafoms-3-1-31.
Texto completoTerrisse, Safae, Laurence Zitvogel y Guido Kroemer. "Impact of microbiota on breast cancer hormone therapy". Cell Stress 7, n.º 3 (13 de marzo de 2023): 12–19. http://dx.doi.org/10.15698/cst2023.03.277.
Texto completoPedroza, Diego A., Ramadevi Subramani y Rajkumar Lakshmanaswamy. "Classical and Non-Classical Progesterone Signaling in Breast Cancers". Cancers 12, n.º 9 (27 de agosto de 2020): 2440. http://dx.doi.org/10.3390/cancers12092440.
Texto completoDika, Emi, Annalisa Patrizi, Martina Lambertini, Nicholas Manuelpillai, Michelangelo Fiorentino, Annalisa Altimari, Manuela Ferracin et al. "Estrogen Receptors and Melanoma: A Review". Cells 8, n.º 11 (19 de noviembre de 2019): 1463. http://dx.doi.org/10.3390/cells8111463.
Texto completoOualla, Karima, Heba M. El-Zawahry, Banu Arun, James M. Reuben, Wendy A. Woodward, Heba Gamal El-Din, Bora Lim, Nawfel Mellas, Naoto T. Ueno y Tamer M. Fouad. "Novel therapeutic strategies in the treatment of triple-negative breast cancer". Therapeutic Advances in Medical Oncology 9, n.º 7 (13 de junio de 2017): 493–511. http://dx.doi.org/10.1177/1758834017711380.
Texto completoMulligan, Michael P., Matthew W. Boudreau, David J. Shapiro, Timothy M. Fan, Paul J. Hergenrother, Kerry Barnhart, David Azorsa, Jeff Kiefer y Spyro Mousses. "Abstract 522: Selective estrogen receptor a-UPR activators (SERA): a novel class of small molecules that eradicate estrogen receptor positive tumors". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 522. http://dx.doi.org/10.1158/1538-7445.am2023-522.
Texto completoSakaguchi, K., H. Nakajima, I. Fujiwara, N. Mizuta y J. Magae. "A novel therapeutic strategy for ER-negative human breast cancers, targeting AP-1 activity". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 14129. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.14129.
Texto completoMiller, Manisha, Lynn Schoenfield, Mohamed Abdel-Rahman y Colleen M. Cebulla. "Is Uveal Melanoma a Hormonally Sensitive Cancer? A Review of the Impact of Sex Hormones and Pregnancy on Uveal Melanoma". Ocular Oncology and Pathology 7, n.º 4 (2021): 239–50. http://dx.doi.org/10.1159/000514650.
Texto completoShen, Minqian, Mengyang Xu, Fanyi Zhong, McKenzie C. Crist, Anjali B. Prior, Kundi Yang, Danielle M. Allaire, Fouad Choueiry, Jiangjiang Zhu y Haifei Shi. "A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2". Cells 10, n.º 2 (20 de febrero de 2021): 455. http://dx.doi.org/10.3390/cells10020455.
Texto completoMoga, Marius Alexandru, Oana Gabriela Dimienescu, Andreea Bălan, Lorena Dima, Sebastian Ionut Toma, Nicușor Florin Bîgiu y Alexandru Blidaru. "Pharmacological and Therapeutic Properties of Punica granatum Phytochemicals: Possible Roles in Breast Cancer". Molecules 26, n.º 4 (17 de febrero de 2021): 1054. http://dx.doi.org/10.3390/molecules26041054.
Texto completoCipolletti, Manuela, Stefania Bartoloni, Claudia Busonero, Martina Parente, Stefano Leone y Filippo Acconcia. "A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells". International Journal of Molecular Sciences 22, n.º 6 (13 de marzo de 2021): 2915. http://dx.doi.org/10.3390/ijms22062915.
Texto completoAsemota, Sarah, Suriyan Ponnusamy, Thirumagal Thiyagarajan y Ramesh Narayanan. "Abstract 1777: Androgen receptor (AR) agonists inhibit AR- and estrogen-receptor-positive breast cancer". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 1777. http://dx.doi.org/10.1158/1538-7445.am2022-1777.
Texto completoVoutsadakis, Ioannis A. "Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations". Clinical Medicine Insights: Oncology 10 (enero de 2016): CMO.S32813. http://dx.doi.org/10.4137/cmo.s32813.
Texto completoBommi-Reddy, Archana, Sungmi Park-Chouinard, David N. Mayhew, Esteban Terzo, Aparna Hingway, Michael J. Steinbaugh, Jonathan E. Wilson, Robert J. Sims y Andrew R. Conery. "CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells". PLOS ONE 17, n.º 3 (30 de marzo de 2022): e0262378. http://dx.doi.org/10.1371/journal.pone.0262378.
Texto completoGustafsson Sheppard, Nina, Nina Heldring y Karin Dahlman-Wright. "Estrogen receptor-α, RBCK1, and protein kinase C β 1 cooperate to regulate estrogen receptor-α gene expression". Journal of Molecular Endocrinology 49, n.º 3 (5 de octubre de 2012): 277–87. http://dx.doi.org/10.1530/jme-12-0073.
Texto completoDoan, Tram B., J. Dinny Graham y Christine L. Clarke. "Emerging functional roles of nuclear receptors in breast cancer". Journal of Molecular Endocrinology 58, n.º 3 (abril de 2017): R169—R190. http://dx.doi.org/10.1530/jme-16-0082.
Texto completo